Dorzolamide

Primary Uses

Dorzolamide is prescribed to treat conditions that cause increased pressure within the eye, also known as intraocular pressure. Lowering this pressure is essential to prevent damage to the optic nerve, which can lead to permanent vision loss or blindness. It is specifically indicated for:

• Open-angle glaucoma: A common form of glaucoma where fluid does not drain properly, causing pressure to build up over time.
• Ocular hypertension: A condition where the pressure inside the eye is higher than the normal range, even if there are no immediate signs of nerve damage or vision loss.

How It Assists in Management

This medication belongs to a class of drugs called carbonic anhydrase inhibitors. It works by reducing the production of fluid (aqueous humor) inside the eye. By decreasing the amount of fluid produced, the medication helps to lower the internal pressure.

Dorzolamide may be used as a standalone treatment or in combination with other types of eye drops, such as beta-blockers, when a single medication is not sufficient to control eye pressure. It is intended for regular, long-term use to manage these chronic conditions.

Mechanism of Action

Dorzolamide belongs to a class of medications known as carbonic anhydrase inhibitors. It works by blocking the activity of an enzyme called carbonic anhydrase II, which is found in the ciliary processes of the eye.

This enzyme plays a critical role in the production of aqueous humor, the clear fluid that fills the front part of the eye. By inhibiting this enzyme, dorzolamide slows down the chemical process that creates the fluid, leading to a decrease in fluid secretion.

Lowering Intraocular Pressure

When the production of aqueous humor is reduced, the overall pressure within the eye, known as intraocular pressure, begins to drop. This mechanism is effective for managing conditions where eye pressure is too high, such as:

• Open-angle glaucoma: A condition where fluid does not drain properly, leading to increased pressure.
• Ocular hypertension: A state of high pressure in the eye without visible nerve damage.

By maintaining lower pressure levels, the medication helps protect the optic nerve from damage that can lead to vision loss.

Common Side Effects

Many people using dorzolamide experience mild side effects shortly after applying the drops. These typically include:

• A bitter, sour, or unusual taste in the mouth
• Burning, stinging, or discomfort in the eye
• Blurred vision
• Eye redness or itching
• Watery eyes
• Headache
• Nausea
• Sensitivity to light

Serious Side Effects

While less common, some side effects can be serious. Contact a healthcare provider immediately if you experience:

• Signs of an allergic reaction, such as skin rash, hives, or swelling of the face, lips, tongue, or throat
• Severe eye pain, swelling, or redness
• Crusting or drainage from the eye
• Vision changes or feeling like something is in the eye
• Signs of kidney stones, such as sharp pain in the side or back, or blood in the urine
• Extreme tiredness or weakness

Because dorzolamide is a sulfonamide medication, it can cause similar allergic reactions to those seen with other sulfa drugs, even when used as an eye drop.

Sulfonamide Sensitivity

Dorzolamide is a sulfonamide. Although it is applied as an eye drop, it is absorbed into the body and can cause the same types of serious adverse reactions as oral sulfonamides. These may include severe skin reactions, such as Stevens-Johnson syndrome, or blood disorders like aplastic anemia. Treatment should be stopped if signs of a serious reaction or hypersensitivity occur.

Eye Health and Safety

There is an increased risk of corneal edema (swelling of the clear front surface of the eye) in patients with low corneal endothelial cell counts. Caution is advised for those with pre-existing corneal issues. Additionally, this medication has not been studied for the treatment of acute angle-closure glaucoma.

To prevent bacterial keratitis (infection of the cornea), the tip of the dispensing container must not touch the eye, surrounding structures, or any other surface. Contamination of the solution can lead to serious eye damage or vision loss.

Medical Conditions

• Kidney and Liver Function: This medication is not recommended for individuals with severe kidney impairment. It should be used with caution in those with liver disease, as it has not been extensively studied in this population.
• Contact Lenses: Many formulations contain benzalkonium chloride, a preservative that can be absorbed by soft contact lenses. Lenses should be removed before applying the drops and may be reinserted after 15 minutes.

Other Precautions

Using dorzolamide eye drops while also taking an oral carbonic anhydrase inhibitor is generally not recommended due to the potential for additive effects on the body.

Pregnancy

There are no adequate and well-controlled studies regarding the use of dorzolamide in pregnant women. In animal studies where the medication was administered orally at high doses, some developmental malformations were observed. These effects occurred at doses significantly higher than those typically absorbed through the eye in humans.

Dorzolamide should be used during pregnancy only if the potential benefit to the patient justifies the potential risk to the fetus. Individuals who are pregnant or planning to become pregnant should discuss their treatment options with a healthcare provider.

Breastfeeding

It is not known whether dorzolamide is excreted in human milk. Because many drugs are passed into breast milk and there is a potential for serious adverse reactions in nursing infants, a choice must be made between discontinuing nursing or discontinuing the drug, taking into account the importance of the medication to the mother.

Consult with a healthcare professional to determine the safest course of action while breastfeeding.

Available Forms

Dorzolamide is provided in the following form:

• Ophthalmic Solution: A sterile liquid medication designed for topical application to the eye.

This medication is typically packaged in a dispenser bottle with a dropper tip designed to deliver individual drops. It is available as a single-ingredient product or in combination with other medications used to manage eye pressure.

FDA Approval and Indications

Dorzolamide hydrochloride ophthalmic solution is approved by the U.S. Food and Drug Administration (FDA) for the treatment of elevated intraocular pressure. It is specifically indicated for patients with the following conditions:

• Open-angle glaucoma: A chronic condition where fluid buildup increases pressure, potentially damaging the optic nerve.
• Ocular hypertension: A condition characterized by higher-than-normal pressure inside the eye without immediate signs of optic nerve damage.

Regulatory Classification

Dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It is available only with a doctor's prescription and is typically supplied as a 2% ophthalmic solution. It may be used alone or in combination with other eye medications, such as beta-blockers, to achieve target eye pressure levels.

Safety and Monitoring

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements associated with dorzolamide. However, because dorzolamide is a sulfonamide derivative, the FDA-approved labeling includes warnings regarding potential systemic absorption. This means that even though it is applied topically to the eye, it may cause side effects similar to those seen with oral sulfonamide medications, including hypersensitivity reactions.

How to Use Dorzolamide Eye Drops

Dorzolamide is typically prescribed as one drop in the affected eye or eyes three times a day. To ensure the medication works effectively and to prevent infection, follow these steps for administration:

• Wash your hands thoroughly before using the drops.
• Tilt your head back and pull down the lower eyelid to create a small pocket.
• Hold the dropper above the eye without touching the tip to your eye, eyelashes, or any other surface.
• Squeeze one drop into the pocket and close your eye gently.
• Apply light pressure to the inside corner of the eye, near the nose, for at least one minute to keep the medicine from draining into the tear duct.

Important Precautions

If you wear soft contact lenses, remove them before applying dorzolamide eye drops. The medication may contain a preservative that can be absorbed by the lenses. You should wait at least 15 minutes after using the drops before putting your contact lenses back in.

If you are using more than one type of eye drop, wait at least five to ten minutes between applying each medication. This prevents the first drop from being washed out by the second one.

Storage and Handling

Keep the bottle tightly closed when not in use and store it at room temperature, away from light and moisture. Do not use the solution if it becomes cloudy, changes color, or if the dropper tip becomes contaminated, as this can lead to serious eye infections.